48Hour Discovery.com Press Releases

• Published on November 21, 2023 - 16:15 GMT

  

  University of Alberta Empowers Breakthroughs: Assigns Comprehensive Patent Portfolio to 48Hour Discovery

  University of Alberta Assigns Full Suite of Patents to 48Hour Discovery as Revenue Exceeds $5 Million Triggering Key Milestone EDMONTON, ALBERTA, CANADA, November 21, 2023 /⁨EINPresswire.com⁩/ -- An Edmonton-based biotechnology company leading the …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
• Published on November 6, 2023 - 08:00 GMT

  

  Orano Med and 48Hour Discovery to Develop Innovative Peptide Receptor Radionuclide Therapy for Targeted Cancer Treatment

  Advancing Precision Medicine: Uniting 212Pb alpha-emitting Radioisotope Peptide Discovery EDMONTON, CANADA, November 6, 2023 /⁨EINPresswire.com⁩/ -- Orano Med, a pioneer in targeted alpha therapy, and 48Hour Discovery, a novel peptide discovery platform …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on October 30, 2023 - 15:30 GMT

  

  48Hour Discovery Reveals New Insight into Cellular Regulation: Breakthrough Discovery for Controlling Cell Activity

  New peptide motif crucial for O-GlcNAc transferase (OGT) regulation discovered promises far-reaching implications for cell physiology and targeted therapies EDMONTON, ALBERTA, CANADA, October 30, 2023 /⁨EINPresswire.com⁩/ -- 48Hour Discovery, a pioneer in …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on October 17, 2023 - 15:00 GMT

  

  48Hour Discovery Accepted into Johnson & Johnson Innovation—JLABS

  Edmonton-based biotech company advances the discovery and development of novel cancer therapeutics EDMONTON, ALBERTA, CANADA, October 17, 2023 /⁨EINPresswire.com⁩/ -- 48Hour Discovery Inc., a leading biotech company focused on peptide drug discovery for …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on September 25, 2023 - 14:15 GMT

  

  New Leadership for 48Hour Discovery: Rick Finnegan Named CEO

  Founder Dr. Ratmir Derda transitions to Chief Scientific Officer as company expands efforts in peptide drug discovery and asset development. EDMONTON, ALBERTA, CANADA, September 25, 2023 /⁨EINPresswire.com⁩/ -- 48Hour Discovery, a leading peptide …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on September 13, 2023 - 15:15 GMT

  

  48Hour Discovery Strengthens Leadership and Scientific Expertise with Three Key Appointments

  Leading peptide discovery company bolsters expertise in radiopharmaceuticals, peptide discovery, and corporate governance. EDMONTON, ALBERTA, CANADA, September 13, 2023 /⁨EINPresswire.com⁩/ -- In a strategic move to enhance its technical capabilities and …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on January 25, 2022 - 14:30 GMT

  

  48Hour Discovery and Fusion Pharmaceuticals to Develop Radiopharmaceuticals for the Treatment of Cancer Tumours

  The goal of the collaboration is to discover novel, peptide-based radiopharmaceuticals for the treatment of various solid tumours. EDMONTON, AB, CANADA, January 25, 2022 /⁨EINPresswire.com⁩/ -- 48Hour Discovery and Fusion Pharmaceuticals to Develop …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on March 15, 2021 - 15:00 GMT

  

  48Hour Discovery and Merck initiate drug discovery project

  -- Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform EDMONTON, AB, CANADA, March 15, 2021 /⁨EINPresswire.com⁩/ -- 48Hour Discovery(48HD) and CQDM are proud to announce that the …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...